Legal Proceedings Report • Sep 13, 2022
Legal Proceedings Report
Open in ViewerOpens in native device viewer
EQS-Ad-hoc: Semperit AG Holding / Key word(s): Miscellaneous Semperit AG Holding identifies probable impairment loss in Medical Sector in the order of approximately EUR 50 million
13-Sep-2022 / 19:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
Vienna, Austria, 13 September 2022 – Against the backdrop of the market dynamics for examination and protective gloves, the Executive Board of Semperit AG Holding reviewed the estimates and assumptions relevant to the valuation with regard to the Medical Sector (Sempermed segment). As a result, a probable impairment loss in the order of approximately EUR 50 million as of 30 September 2022 was identified for the segment assets of Sempermed.
The exact amount of the impairment loss will be included in the third quarter business development figures and will be disclosed at the latest with the publication of the Q1-3 2022 results on 16 November 2022.
Monika Riedel Director Group Brand Management, Corporate Spokesperson +43 676 8715 8620 [email protected]
Judit Helenyi Director Investor Relations +43 676 8715 8310 [email protected]
www.linkedin.com/company/semperit-ag
| Language: Company: |
English Semperit AG Holding |
|---|---|
| Am Belvedere 10 | |
| 1100 Wien | |
| Austria | |
| Phone: | +43 1 79 777-310 |
| Fax: | +43 1 79 777-602 |
| E-mail: | [email protected] |
| Internet: | www.semperitgroup.com |
| ISIN: | AT0000785555 |
| Listed: | Vienna Stock Exchange (Official Market) |
| EQS News ID: | 1441759 |
End of Announcement EQS News Service
Have a question? We'll get back to you promptly.